"Pfizer signs agreement to acquire Arena Pharmaceuticals for $6.7bn" https://www.pharmaceutical-technology.com/news/pfizer-agreement-arena-pharmaceuticals/
Faizer bought Arena Pharmaceuticals. The deal was closed for $ 6.7 billion. Profits from vaccines were well invested - Arena deals with drugs for cardiovascular disease.
Learn how to do business!
Faizer bought Arena Pharmaceuticals. The deal was closed for $ 6.7 billion. Profits from vaccines were well invested - Arena deals with drugs for cardiovascular disease.
Learn how to do business!
Pharmaceutical Technology
Pfizer concludes Arena Pharmaceuticals acquisition for $6.7bn
Pfizer will gain access to Arena’s portfolio of various treatment candidates for gastroenterology, dermatology and cardiology.
This media is not supported in your browser
VIEW IN TELEGRAM
Conspiracy theory they said!
Forwarded from Natalia Prego Cancelo MD, Dra, oficial Canal de difusión (Natalia Prego Cancelo)
Rumble
ES PENA QUE LOS COLEGIOS DE MÉDICOS PERSIGAN A LOS MÉDICOS Y NO TENGAN LIBERTAD DE EXPRESIÓN COMO YO
Los que tenemos claro que eso no es una pandemia, que esto no tiene nada que ver con la salud, esto es un tema político y yo creo que ha llegado la hora también de hablar claramente, ya no podemos ir
👍1
The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome - ScienceDirect
https://www.sciencedirect.com/science/article/pii/S0264410X20312548
https://www.sciencedirect.com/science/article/pii/S0264410X20312548
Sciencedirect
The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome
Underreporting is a limitation common to passive surveillance systems, including the Vaccine Adverse Event Reporting System (VAERS) that monitors the …
👍2
Forwarded from Dr. Peter McCullough [FAKE]
Please open Telegram to view this post
VIEW IN TELEGRAM